Literature DB >> 15223826

Encapsulated cell-based intraocular delivery of ciliary neurotrophic factor in normal rabbit: dose-dependent effects on ERG and retinal histology.

Ronald A Bush1, Bo Lei, Weng Tao, Dorit Raz, Chi-Chao Chan, Terry A Cox, Maria Santos-Muffley, Paul A Sieving.   

Abstract

PURPOSE: ERG and histologic changes were investigated in normal rabbits after intravitreal implantation of encapsulated cell technology (ECT) devices releasing ciliary neurotrophic factor (CNTF).
METHODS: Fifteen adult New Zealand White albino rabbits had ECT devices secreting CNTF at 22, 5, or 0 ng/d implanted in the superior temporal quadrant of the left eye. The low dose has been shown to produce substantial rescue of photoreceptors in the rcd1 canine model of retinal degeneration. Right eyes were untreated. Ganzfeld dark- and light-adapted ERGs and clinical observations were performed at 5, 15, and 25 days after implantation. Rod a-waves and rod and cone b-waves and outer nuclear layer (ONL) morphology were evaluated at 25 days.
RESULTS: Clinical examination showed minimal changes in a few CNTF-treated eyes, including vitreous membranes and engorgement of iris vessels at day 25. Retinas appeared normal. CNTF did not significantly affect the rod a- or b-waves, although the b-wave amplitude tended to be larger in CNTF-treated retinas at low flash intensities. The cone b-wave amplitude was significantly reduced in high-dose eyes at some flash intensities. The ONL area in high-dose eyes was significantly greater because of increased thickness than in fellow retinas. ONL cell size was significantly increased, and staining density decreased in CNTF-treated retinas.
CONCLUSIONS: CNTF, given by intravitreal ECT device at doses that protect photoreceptors in a canine model of retinal degeneration (5 ng/d), did not adversely affect either rod or cone ERG function of normal rabbit retina. The cone ERG was more sensitive to suppression being reduced, at low flash intensities, by 22 ng/d. Dose-related changes in the ONL and photoreceptor cell nuclei did not represent a toxic effect, because they were not associated with deficits in the rod ERG over a broad range of intensities.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15223826     DOI: 10.1167/iovs.03-1342

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  31 in total

Review 1.  Emerging therapeutic approaches in the management of retinal angiogenesis and edema.

Authors:  An Truong; Tien Y Wong; Levon M Khachigian
Journal:  J Mol Med (Berl)       Date:  2010-12-18       Impact factor: 4.599

2.  Can we grow new retina?

Authors:  Geeta K Vemuganti
Journal:  Community Eye Health       Date:  2006-03

Review 3.  Surgical approaches to gene and stem cell therapy for retinal disease.

Authors:  J Timothy Stout; Peter J Francis
Journal:  Hum Gene Ther       Date:  2011-05       Impact factor: 5.695

4.  Test-retest reliability of scotopic full-field electroretinograms in rabbits.

Authors:  Jan Luebke; Alexandra Anton; Michael Bach
Journal:  Doc Ophthalmol       Date:  2017-03-16       Impact factor: 2.379

5.  Ciliary neurotrophic factor (CNTF) protects retinal cone and rod photoreceptors by suppressing excessive formation of the visual pigments.

Authors:  Songhua Li; Kota Sato; William C Gordon; Michael Sendtner; Nicolas G Bazan; Minghao Jin
Journal:  J Biol Chem       Date:  2018-08-16       Impact factor: 5.157

6.  Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration.

Authors:  Kang Zhang; Jill J Hopkins; Jeffrey S Heier; David G Birch; Lawrence S Halperin; Thomas A Albini; David M Brown; Glenn J Jaffe; Weng Tao; George A Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-28       Impact factor: 11.205

Review 7.  CNTF and retina.

Authors:  Rong Wen; Weng Tao; Yiwen Li; Paul A Sieving
Journal:  Prog Retin Eye Res       Date:  2011-12-10       Impact factor: 21.198

8.  Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants.

Authors:  Paul A Sieving; Rafael C Caruso; Weng Tao; Hanna R Coleman; Darby J S Thompson; Keri R Fullmer; Ronald A Bush
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-27       Impact factor: 11.205

9.  Long-term Follow-up of Patients With Retinitis Pigmentosa Receiving Intraocular Ciliary Neurotrophic Factor Implants.

Authors:  David G Birch; Lea D Bennett; Jacque L Duncan; Richard G Weleber; Mark E Pennesi
Journal:  Am J Ophthalmol       Date:  2016-07-25       Impact factor: 5.258

10.  CNTF-mediated protection of photoreceptors requires initial activation of the cytokine receptor gp130 in Müller glial cells.

Authors:  Kun Do Rhee; Steven Nusinowitz; Kevin Chao; Fei Yu; Dean Bok; Xian-Jie Yang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.